Responsive image

Common name


N,3,3-trimethylbutanamide

IUPAC name


N,3,3-trimethylbutanamide

SMILES


O=C(NC)CC(C)(C)C

Common name


N,3,3-trimethylbutanamide

IUPAC name


N,3,3-trimethylbutanamide

SMILES


O=C(NC)CC(C)(C)C

INCHI


InChI=1S/C7H15NO/c1-7(2,3)5-6(9)8-4/h5H2,1-4H3,(H,8,9)

FORMULA


C7H15NO

Responsive image

Common name


N,3,3-trimethylbutanamide

IUPAC name


N,3,3-trimethylbutanamide





Molecular weight


129.200

clogP


0.851

clogS


-1.844

Frequency


0.0007





HBond Acceptor


1

HBond Donor


1

Total Polar
Surface Area


29.1

Number of Rings


0

Rotatable Bond


2

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00648 Marimastat Responsive image Enzyme Inhibitors; For the treatment of various cancers.
FDBD00923 Atazanavir Responsive image Anti-HIV Agents; Protease Inhibitors; HIV Protease Inhibitors; Antiinfectives for Systemic Use; Direct Acting Antivirals; Antivirals for Systemic Use; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.
2 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
2xye_ligand_2_42.mol2 2xye 1 -6.64 C(=O)(NC)CC(C)(C)C 9
2xyf_ligand_2_42.mol2 2xyf 1 -6.63 N(C(=O)CC(C)(C)C)C 9
1jld_ligand_4_2314.mol2 1jld 1 -6.59 [C@@H](C(=O)NC)(C)C(C)(C)C 10
2o4k_ligand_3_105.mol2 2o4k 1 -6.55 C(C)(C)(C)CC(=O)NC 9
3ekw_ligand_3_105.mol2 3ekw 1 -6.54 CNC(=O)CC(C)(C)C 9
3eky_ligand_3_105.mol2 3eky 1 -6.53 CNC(=O)CC(C)(C)C 9
3el9_ligand_3_105.mol2 3el9 1 -6.50 C(C(=O)NC)C(C)(C)C 9
2aqu_ligand_3_105.mol2 2aqu 1 -6.49 C(C(=O)NC)C(C)(C)C 9
387 , 39